BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21518332)

  • 1. Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
    Ogura M; Todo T; Tanaka M; Nannya Y; Ichikawa M; Nakamura F; Kurokawa M
    Br J Haematol; 2011 Sep; 154(5):663-5. PubMed ID: 21518332
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
    Momota H; Narita Y; Miyakita Y; Hosono A; Makimoto A; Shibui S
    Pediatr Blood Cancer; 2010 Sep; 55(3):577-9. PubMed ID: 20658636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN; Lin YC; Liu MY; Chang PY
    J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.
    Merlin F; Prochilo T; Kildani B; Tucci A; Ferrari S; Rossi G; D'Adda P; Beretta GD
    Acta Oncol; 2008; 47(3):464-6. PubMed ID: 17851873
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
    Neyns B; Cordera S; Joosens E; Pouratian N
    J Clin Oncol; 2008 Sep; 26(27):4518-9. PubMed ID: 18802168
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-Hodgkin lymphoma following temozolomide.
    Sharma A; Gupta D; Mohanti BK; Thulkar S; Dwary A; Goyal S; Muzumder S; Das P
    Pediatr Blood Cancer; 2009 Oct; 53(4):661-2. PubMed ID: 19533661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Ph+ acute lymphoblastic leukemia after temozolomide.
    De Vita S; De Matteis S; Laurenti L; Chiusolo P; Reddiconto G; Fiorini A; Leone G; Sica S
    Ann Hematol; 2005 Oct; 84(11):760-2. PubMed ID: 16044311
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I study of temozolomide in relapsed/refractory acute leukemia.
    Seiter K; Liu D; Loughran T; Siddiqui A; Baskind P; Ahmed T
    J Clin Oncol; 2002 Aug; 20(15):3249-53. PubMed ID: 12149298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
    De Vos FY; Gijtenbeek JM; Bleeker-Rovers CP; van Herpen CM
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):373-82. PubMed ID: 22925496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma.
    Lau LG; Tan LK; Koay ES; Liu TC
    Leukemia; 2005 Feb; 19(2):299-301. PubMed ID: 15526017
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible leukemogenic potential of temozolomide.
    Weiss B; Geiger H; Davies SM
    Pediatr Blood Cancer; 2009 Apr; 52(4):553. PubMed ID: 19058212
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Lymphoblastic Leukemia after previously treated, relapsed Chronic Lymphocytic Leukemia: A Case Report.
    Andrus E; Nicolescu A; Bumbea H; Vlădăreanu AM
    Rom J Intern Med; 2015; 53(2):184-8. PubMed ID: 26402989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
    Sure D; Dunn I; Norden A; Anderson WS
    Clin Neurol Neurosurg; 2010 Oct; 112(8):741-2. PubMed ID: 20434832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is protracted low-dose temozolomide feasible in glioma patients?
    Wong ET
    Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma".
    Gousias K; Kyritsis A
    J Clin Neurosci; 2010 Mar; 17(3):412. PubMed ID: 20079651
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse of herpes encephalitis induced by temozolomide-based chemoradiation in a patient with malignant glioma.
    Okada M; Miyake K; Shinomiya A; Kawai N; Tamiya T
    J Neurosurg; 2013 Feb; 118(2):258-63. PubMed ID: 23101441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.
    Morris EB; Kasow K; Reiss U; Ellison D; Broniscer A
    J Neurooncol; 2009 Jan; 91(2):237-9. PubMed ID: 18818880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
    Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
    Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
    [No Abstract]   [Full Text] [Related]  

  • 20. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
    Yaman E; Coskun U; Ozturk B; Buyukberber S; Kaya AO; Coskun O; Buyukberber N; Yildiz R; Benekli M
    J Clin Neurosci; 2009 Apr; 16(4):591-2. PubMed ID: 19201195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.